{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:43:00Z","timestamp":1790174580316,"version":"4.1.0"},"reference-count":34,"publisher":"National Academy of Sciences","issue":"17","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2014,4,29]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>We have developed a new class of host-targeted biologics to prevent influenza by engineering multivalent carbohydrate-binding modules that bind with high affinity to sialic acid, the critical component of the influenza virus cell surface receptor. Mouse studies reveal a remarkable efficacy: a single 1-\u03bcg dose of the lead biologic given 7 d before a lethal challenge with 2009 pandemic H1N1 influenza virus provides complete protection. This new approach has the potential to be a front-line defense against any current and future influenza virus, overcoming viral escape to vaccines and antivirals. In addition, the biologics may have broader application against other respiratory pathogens.<\/jats:p>","DOI":"10.1073\/pnas.1404205111","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T23:58:43Z","timestamp":1397519923000},"page":"6401-6406","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":43,"title":["Prevention of influenza by targeting host receptors using engineered proteins"],"prefix":"10.1073","volume":"111","author":[{"given":"Helen","family":"Connaris","sequence":"first","affiliation":[{"name":"Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Govorkova","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Ligertwood","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush EH25 9RG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette M.","family":"Dutia","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush EH25 9RG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Tauber","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiawati","family":"Alias","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hagan","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Nash","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush EH25 9RG, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry L.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2014,4,14]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cell.2009.01.029","article-title":"The influenza virus enigma","volume":"136","author":"Salomon R","year":"2009","unstructured":"R Salomon, RG Webster, The influenza virus enigma. Cell 136, 402\u2013410 (2009).","journal-title":"Cell"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao R","year":"2013","unstructured":"R Gao, et al., Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368, 1888\u20131897 (2013).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai M","year":"2012","unstructured":"M Imai, et al., Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets. Nature 486, 420\u2013428 (2012).","journal-title":"Nature"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst S","year":"2012","unstructured":"S Herfst, et al., Airborne transmission of influenza A\/H5N1 virus between ferrets. Science 336, 1534\u20131541 (2012).","journal-title":"Science"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1222526","article-title":"The potential for respiratory droplet-transmissible A\/H5N1 influenza virus to evolve in a mammalian host","volume":"336","author":"Russell CA","year":"2012","unstructured":"CA Russell, et al., The potential for respiratory droplet-transmissible A\/H5N1 influenza virus to evolve in a mammalian host. Science 336, 1541\u20131547 (2012).","journal-title":"Science"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(13)61125-3","article-title":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance","volume":"381","author":"Hu Y","year":"2013","unstructured":"Y Hu, et al., Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 381, 2273\u20132279 (2013).","journal-title":"Lancet"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMc0910060","article-title":"Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis","volume":"361","author":"Baz M","year":"2009","unstructured":"M Baz, et al., Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 361, 2296\u20132297 (2009).","journal-title":"N Engl J Med"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin","volume":"69","author":"Skehel JJ","year":"2000","unstructured":"JJ Skehel, DC Wiley, Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem 69, 531\u2013569 (2000).","journal-title":"Annu Rev Biochem"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/JVI.75.10.4604-4613.2001","article-title":"Receptor specificities of human respiroviruses","volume":"75","author":"Suzuki T","year":"2001","unstructured":"T Suzuki, et al., Receptor specificities of human respiroviruses. J Virol 75, 4604\u20134613 (2001).","journal-title":"J Virol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10719-006-5437-9","article-title":"Sialic acids as receptor determinants for coronaviruses","volume":"23","author":"Schwegmann-Wessels C","year":"2006","unstructured":"C Schwegmann-Wessels, G Herrler, Sialic acids as receptor determinants for coronaviruses. Glycoconj J 23, 51\u201358 (2006).","journal-title":"Glycoconj J"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/598483","article-title":"Sialic acid: A preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host","volume":"199","author":"Trappetti C","year":"2009","unstructured":"C Trappetti, et al., Sialic acid: A preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host. J Infect Dis 199, 1497\u20131505 (2009).","journal-title":"J Infect Dis"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/440435a","article-title":"Avian flu: Influenza virus receptors in the human airway","volume":"440","author":"Shinya K","year":"2006","unstructured":"K Shinya, et al., Avian flu: Influenza virus receptors in the human airway. Nature 440, 435\u2013436 (2006).","journal-title":"Nature"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"e1003223","DOI":"10.1371\/journal.ppat.1003223","article-title":"Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection","volume":"9","author":"Walther T","year":"2013","unstructured":"T Walther, et al., Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection. PLoS Pathog 9, e1003223 (2013).","journal-title":"PLoS Pathog"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nature12372","article-title":"Receptor binding by an H7N9 influenza virus from humans","volume":"499","author":"Xiong X","year":"2013","unstructured":"X Xiong, et al., Receptor binding by an H7N9 influenza virus from humans. Nature 499, 496\u2013499 (2013).","journal-title":"Nature"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature12379","article-title":"Biological features of novel avian influenza A (H7N9) virus","volume":"499","author":"Zhou J","year":"2013","unstructured":"J Zhou, et al., Biological features of novel avian influenza A (H7N9) virus. Nature 499, 500\u2013503 (2013).","journal-title":"Nature"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","article-title":"Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors","volume":"37","author":"Mammen M","year":"1998","unstructured":"M Mammen, SK Choi, GM Whitesides, Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37, 2755\u20132794 (1998).","journal-title":"Angew Chem Int Ed"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.1074\/jbc.M807398200","article-title":"Enhancing the receptor affinity of the sialic acid-binding domain of Vibrio cholerae sialidase through multivalency","volume":"284","author":"Connaris H","year":"2009","unstructured":"H Connaris, PR Crocker, GL Taylor, Enhancing the receptor affinity of the sialic acid-binding domain of Vibrio cholerae sialidase through multivalency. J Biol Chem 284, 7339\u20137351 (2009).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"40819","DOI":"10.1074\/jbc.M404965200","article-title":"Sialic acid recognition by Vibrio cholerae neuraminidase","volume":"279","author":"Moustafa I","year":"2004","unstructured":"I Moustafa, et al., Sialic acid recognition by Vibrio cholerae neuraminidase. J Biol Chem 279, 40819\u201340826 (2004).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jmb.2008.12.084","article-title":"Structural studies on the Pseudomonas aeruginosa sialidase-like enzyme PA2794 suggest substrate and mechanistic variations","volume":"386","author":"Xu G","year":"2009","unstructured":"G Xu, C Ryan, MJ Kiefel, JC Wilson, GL Taylor, Structural studies on the Pseudomonas aeruginosa sialidase-like enzyme PA2794 suggest substrate and mechanistic variations. J Mol Biol 386, 828\u2013840 (2009).","journal-title":"J Mol Biol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1107\/S1744309108024044","article-title":"Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA","volume":"64","author":"Xu G","year":"2008","unstructured":"G Xu, X Li, PW Andrew, GL Taylor, Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA. Acta Crystallogr Sect F Struct Biol Cryst Commun 64, 772\u2013775 (2008).","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1073\/pnas.1014739108","article-title":"Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift","volume":"108","author":"Cantor JR","year":"2011","unstructured":"JR Cantor, et al., Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proc Natl Acad Sci USA 108, 1272\u20131277 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1462-5822.2010.01490.x","article-title":"Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization","volume":"12","author":"Banerjee A","year":"2010","unstructured":"A Banerjee, et al., Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cell Microbiol 12, 1576\u20131588 (2010).","journal-title":"Cell Microbiol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","article-title":"Broadly neutralizing antibodies against influenza virus and prospects for universal therapies","volume":"2","author":"Ekiert DC","year":"2012","unstructured":"DC Ekiert, IA Wilson, Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2, 134\u2013141 (2012).","journal-title":"Curr Opin Virol"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1098\/rstb.2011.0102","article-title":"Towards universal influenza vaccines?","volume":"366","author":"Osterhaus A","year":"2011","unstructured":"A Osterhaus, R Fouchier, G Rimmelzwaan, Towards universal influenza vaccines? Philos Trans R Soc Lond B Biol Sci 366, 2766\u20132773 (2011).","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2165\/11537960-000000000-00000","article-title":"Drugs in development for influenza","volume":"70","author":"Boltz DA","year":"2010","unstructured":"DA Boltz, JR Aldridge, RG Webster, EA Govorkova, Drugs in development for influenza. Drugs 70, 1349\u20131362 (2010).","journal-title":"Drugs"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1515\/BC.2011.121","article-title":"Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections","volume":"392","author":"Ludwig S","year":"2011","unstructured":"S Ludwig, Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biol Chem 392, 837\u2013847 (2011).","journal-title":"Biol Chem"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/infdis\/jis622","article-title":"A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection","volume":"206","author":"Moss RB","year":"2012","unstructured":"RB Moss, et al., A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection. J Infect Dis 206, 1844\u20131851 (2012).","journal-title":"J Infect Dis"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection","volume":"50","author":"Malakhov MP","year":"2006","unstructured":"MP Malakhov, et al., Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob Agents Chemother 50, 1470\u20131479 (2006).","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/522609","article-title":"DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection","volume":"196","author":"Belser JA","year":"2007","unstructured":"JA Belser, et al., DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 196, 1493\u20131499 (2007).","journal-title":"J Infect Dis"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"e7788","DOI":"10.1371\/journal.pone.0007788","article-title":"Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein","volume":"4","author":"Triana-Baltzer GB","year":"2009","unstructured":"GB Triana-Baltzer, et al., Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS ONE 4, e7788 (2009).","journal-title":"PLoS ONE"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.109.162149","article-title":"Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells","volume":"333","author":"Yamaya M","year":"2010","unstructured":"M Yamaya, et al., Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells. J Pharmacol Exp Ther 333, 81\u201390 (2010).","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06517.x","article-title":"Multifarious roles of sialic acids in immunity","volume":"1253","author":"Varki A","year":"2012","unstructured":"A Varki, P Gagneux, Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 1253, 16\u201336 (2012).","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nature05816","article-title":"Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins","volume":"446","author":"Varki A","year":"2007","unstructured":"A Varki, Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature 446, 1023\u20131029 (2007).","journal-title":"Nature"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness","volume":"198","author":"Morens DM","year":"2008","unstructured":"DM Morens, JK Taubenberger, AS Fauci, Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J Infect Dis 198, 962\u2013970 (2008).","journal-title":"J Infect Dis"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1404205111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T07:07:58Z","timestamp":1654585678000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1404205111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,14]]},"references-count":34,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,4,29]]}},"alternative-id":["10.1073\/pnas.1404205111"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1404205111","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,14]]},"assertion":[{"value":"2014-04-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}